Psychedelic-assisted therapy (PAT) may be safe and effective for various mental health conditions, including eating disorders such as anorexia nervosa. Classic psychedelics could have transdiagnostic benefits through mechanisms relevant to eating disorder pathology. Interest in and efforts to increase access to PAT are high, but early clinical trials are focused on safety and utility, with efficacy remaining unclear. High-quality published data supporting PAT for eating disorders is lacking, though recent studies suggest it may augment current interventions for these difficult-to-treat conditions.
Psychedelic-assisted therapies, using substances like LSD and psilocybin, are being explored as potential treatments for eating disorders such as anorexia nervosa. These psychedelics may influence biological and psychological processes relevant to the disorders' underlying causes. Early clinical trials are investigating safety and therapeutic potential, but definitive evidence is still lacking. Preliminary studies suggest these therapies could improve the effectiveness of existing treatments, though high-quality research is needed to confirm efficacy. Caution is advised against premature legalization and marketing of psychedelics for these serious conditions.